{"id":8125,"date":"2025-12-22T15:34:12","date_gmt":"2025-12-22T06:34:12","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4530\/"},"modified":"2026-08-23T13:45:04","modified_gmt":"2026-08-23T04:45:04","slug":"company-4530","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4530\/","title":{"rendered":"HISAMITSU PHARMACEUTICAL CO INC"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4530","DATE":"2025-12-26","longName":"Hisamitsu Pharmaceutical Co Inc","company_name_ja":"\u4e45\u5149\u88fd\u85ac(\u682a)","fullTimeEmployees":2799,"address":"","phone":"","website":"https:\/\/www.global.hisamitsu","industry":"Drug Manufacturers - Specialty & Generic","sector":"Healthcare","regularMarketPrice":4394,"financialCurrency":"","marketCap":307785,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":156006000000,"OperatingIncome":18896000000,"operatingMargins":12.109999999999999,"NetIncome":21758000000,"profitMargins":13.949999999999999,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":7.8600000000000003,"recommendationMean":3,"recommendationKey":"hold","targetMeanPrice":4300,"numberOfAnalystOpinions":1,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-07-01T06:03:52.264160\", \"ticker\": \"4530\", \"ticker_full\": \"4530.T\", \"company_name\": \"HISAMITSU PHARMACEUTICAL CO INC\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"0\", \"strong_buy\": 0, \"buy\": 0, \"hold\": 1, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 1, \"recommendation_key\": \"hold\", \"recommendation_mean\": 3.0}, \"target_prices\": {\"has_data\": true, \"current\": 6040.0, \"high\": 4300.0, \"low\": 4300.0, \"mean\": 4300.0, \"median\": 4300.0}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": {\"date\": \"2026-07-09\", \"eps_estimate\": 68.8, \"eps_actual\": null, \"surprise_pct\": null}, \"future_count\": 1, \"past_earnings\": [{\"date\": \"2025-07-09\", \"eps_estimate\": 68.8, \"eps_actual\": 35.14, \"surprise_pct\": -48.92}, {\"date\": \"2024-07-11\", \"eps_estimate\": 43.6, \"eps_actual\": 63.89, \"surprise_pct\": 46.54}, {\"date\": \"2023-07-13\", \"eps_estimate\": 19.4, \"eps_actual\": 52.09, \"surprise_pct\": 168.51}, {\"date\": \"2022-07-07\", \"eps_estimate\": 22.2, \"eps_actual\": 20.46, \"surprise_pct\": -7.84}, {\"date\": \"2021-07-07\", \"eps_estimate\": 20.8, \"eps_actual\": 28.91, \"surprise_pct\": 38.99}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 84.39, \"institution_pct\": 32.17, \"major_holders\": [{\"label\": \"\", \"value\": 84.39}, {\"label\": \"\", \"value\": 32.17}, {\"label\": \"\", \"value\": 2.06}, {\"label\": \"\", \"value\": 85.0}], \"institutional_holders\": [{\"holder\": \"VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund\", \"shares\": 750694, \"date_reported\": \"2026-01-31\", \"pct_held\": 1.0, \"pct_change\": 0.0, \"value\": 4534191760}, {\"holder\": \"VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund\", \"shares\": 484563, \"date_reported\": \"2025-12-31\", \"pct_held\": 0.64, \"pct_change\": 2.56, \"value\": 2926760520}, {\"holder\": \"DFA INVESTMENT TRUST CO-The Japanese Small Company Series\", \"shares\": 175268, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.23, \"pct_change\": 26.12, \"value\": 1058618720}, {\"holder\": \"DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.\", \"shares\": 165908, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.22, \"pct_change\": 6.14, \"value\": 1002084320}, {\"holder\": \"iShares Trust-iShares Core MSCI EAFE ETF\", \"shares\": 133600, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.18, \"pct_change\": 0.0, \"value\": 806944000}, {\"holder\": \"VANGUARD WHITEHALL Fd.S-Vanguard Intl Dividend Appreciation Index Fd.\", \"shares\": 124900, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.17, \"pct_change\": -2.5, \"value\": 754396000}, {\"holder\": \"VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Index Fd.\", \"shares\": 116796, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.16, \"pct_change\": 0.0, \"value\": 705447840}, {\"holder\": \"Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund\", \"shares\": 103900, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.14, \"pct_change\": 0.0, \"value\": 627556000}, {\"holder\": \"iShares Trust-iShares Core MSCI Total International Stock ETF\", \"shares\": 81500, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.11, \"pct_change\": 0.0, \"value\": 492260000}, {\"holder\": \"iShares Trust-iShares MSCI EAFE Small-Cap ETF\", \"shares\": 74000, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.1, \"pct_change\": 1.37, \"value\": 446960000}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company offers OTC products, such as external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. It also exports its products to Asia, the United States, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. As of February 19, 2026, Hisamitsu Pharmaceutical Co., Inc. operates as a subsidiary of Taiyo Kosan Co., Ltd.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":60,"get_dividend_history_year2":87.5,"get_dividend_history_year3":84.75,"get_dividend_history_year4":84.25,"get_dividend_history_year5":83.75,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-07-12T04:57:53.600308\", \"ticker\": \"4530\", \"ticker_full\": \"4530.T\", \"company_name\": \"HISAMITSU PHARMACEUTICAL CO INC\", \"company_info\": {\"name_en\": \"HISAMITSU PHARMACEUTICAL CO INC\", \"long_name\": \"Hisamitsu Pharmaceutical Co Inc\", \"sector\": \"Healthcare\", \"industry\": \"Drug Manufacturers - Specialty & Generic\", \"website\": \"https:\/\/www.global.hisamitsu\", \"employees\": null, \"country\": \"Japan\", \"city\": \"Tosu\", \"address\": \"Tashirodaikan-machi 408\", \"description\": \"Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company offers OTC products, such as external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. It also exports its products to Asia, the United States, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. As of February 19, 2026, Hisamitsu Pharmaceutical Co., Inc. operates as a subsidiary of Taiyo Kosan Co., Ltd.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 0, \"deviation\": 0, \"trend\": \"neutral\"}, \"ma_25\": {\"ma_value\": 0, \"deviation\": 0, \"trend\": \"neutral\"}, \"ma_75\": {\"ma_value\": 0, \"deviation\": 0, \"trend\": \"neutral\"}, \"ma_200\": {\"ma_value\": 0, \"deviation\": 0, \"trend\": \"neutral\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 156006000000.0, \"revenue_fmt\": \"\u00a51560\u5104\", \"gross_profit\": 91196000000.0, \"gross_profit_fmt\": \"\u00a5912\u5104\", \"operating_income\": 18896000000.0, \"operating_income_fmt\": \"\u00a5189\u5104\", \"ebit\": 28710000000.0, \"ebit_fmt\": \"\u00a5287\u5104\", \"net_income\": 21758000000.0, \"net_income_fmt\": \"\u00a5218\u5104\", \"eps\": 0, \"operating_margin\": 12.11, \"total_assets\": 343068000000.0, \"total_assets_fmt\": \"\u00a53431\u5104\", \"total_equity\": 276822000000.0, \"total_equity_fmt\": \"\u00a52768\u5104\", \"total_debt\": 3856000000.0, \"total_debt_fmt\": \"\u00a539\u5104\", \"total_cash\": 114518000000.0, \"total_cash_fmt\": \"\u00a51145\u5104\", \"equity_ratio\": 80.69, \"de_ratio\": 0.01, \"current_ratio\": 4.32, \"operating_cf\": 18765000000.0, \"operating_cf_fmt\": \"\u00a5188\u5104\", \"investing_cf\": 17563000000.0, \"investing_cf_fmt\": \"\u00a5176\u5104\", \"financing_cf\": -15850000000.0, \"financing_cf_fmt\": \"-\u00a5158\u5104\", \"free_cf\": 4991000000.0, \"free_cf_fmt\": \"\u00a550\u5104\", \"net_margin\": 13.95, \"roe\": 7.86, \"roa\": 6.34}, {\"year\": 2024, \"revenue\": 141706000000.0, \"revenue_fmt\": \"\u00a51417\u5104\", \"gross_profit\": 78970000000.0, \"gross_profit_fmt\": \"\u00a5790\u5104\", \"operating_income\": 13167000000.0, \"operating_income_fmt\": \"\u00a5132\u5104\", \"ebit\": 19204000000.0, \"ebit_fmt\": \"\u00a5192\u5104\", \"net_income\": 13969000000.0, \"net_income_fmt\": \"\u00a5140\u5104\", \"eps\": 0, \"operating_margin\": 9.29, \"total_assets\": 328779000000.0, \"total_assets_fmt\": \"\u00a53288\u5104\", \"total_equity\": 264871000000.0, \"total_equity_fmt\": \"\u00a52649\u5104\", \"total_debt\": 2100000000.0, \"total_debt_fmt\": \"\u00a521\u5104\", \"total_cash\": 112459000000.0, \"total_cash_fmt\": \"\u00a51125\u5104\", \"equity_ratio\": 80.56, \"de_ratio\": 0.01, \"current_ratio\": 4.22, \"operating_cf\": 18188000000.0, \"operating_cf_fmt\": \"\u00a5182\u5104\", \"investing_cf\": -2512000000.0, \"investing_cf_fmt\": \"-\u00a525\u5104\", \"financing_cf\": -16691000000.0, \"financing_cf_fmt\": \"-\u00a5167\u5104\", \"free_cf\": 5152000000.0, \"free_cf_fmt\": \"\u00a552\u5104\", \"net_margin\": 9.86, \"roe\": 5.27, \"roa\": 4.25}, {\"year\": 2023, \"revenue\": 128330000000.0, \"revenue_fmt\": \"\u00a51283\u5104\", \"gross_profit\": 72699000000.0, \"gross_profit_fmt\": \"\u00a5727\u5104\", \"operating_income\": 11600000000.0, \"operating_income_fmt\": \"\u00a5116\u5104\", \"ebit\": 16128000000.0, \"ebit_fmt\": \"\u00a5161\u5104\", \"net_income\": 11742000000.0, \"net_income_fmt\": \"\u00a5117\u5104\", \"eps\": 0, \"operating_margin\": 9.04, \"total_assets\": 313917000000.0, \"total_assets_fmt\": \"\u00a53139\u5104\", \"total_equity\": 256362000000.0, \"total_equity_fmt\": \"\u00a52564\u5104\", \"total_debt\": 2295000000.0, \"total_debt_fmt\": \"\u00a523\u5104\", \"total_cash\": 122154000000.0, \"total_cash_fmt\": \"\u00a51222\u5104\", \"equity_ratio\": 81.67, \"de_ratio\": 0.01, \"current_ratio\": 4.68, \"operating_cf\": 12727000000.0, \"operating_cf_fmt\": \"\u00a5127\u5104\", \"investing_cf\": -23868000000.0, \"investing_cf_fmt\": \"-\u00a5239\u5104\", \"financing_cf\": -14687000000.0, \"financing_cf_fmt\": \"-\u00a5147\u5104\", \"free_cf\": 4819000000.0, \"free_cf_fmt\": \"\u00a548\u5104\", \"net_margin\": 9.15, \"roe\": 4.58, \"roa\": 3.74}, {\"year\": 2022, \"revenue\": 120193000000.0, \"revenue_fmt\": \"\u00a51202\u5104\", \"gross_profit\": 70067000000.0, \"gross_profit_fmt\": \"\u00a5701\u5104\", \"operating_income\": 9337000000.0, \"operating_income_fmt\": \"\u00a593\u5104\", \"ebit\": 12976000000.0, \"ebit_fmt\": \"\u00a5130\u5104\", \"net_income\": 9658000000.0, \"net_income_fmt\": \"\u00a597\u5104\", \"eps\": 0, \"operating_margin\": 7.77, \"total_assets\": 302858000000.0, \"total_assets_fmt\": \"\u00a53029\u5104\", \"total_equity\": 253165000000.0, \"total_equity_fmt\": \"\u00a52532\u5104\", \"total_debt\": 2460000000.0, \"total_debt_fmt\": \"\u00a525\u5104\", \"total_cash\": 129290000000.0, \"total_cash_fmt\": \"\u00a51293\u5104\", \"equity_ratio\": 83.59, \"de_ratio\": 0.01, \"current_ratio\": 6.22, \"operating_cf\": 19199000000.0, \"operating_cf_fmt\": \"\u00a5192\u5104\", \"investing_cf\": -13060000000.0, \"investing_cf_fmt\": \"-\u00a5131\u5104\", \"financing_cf\": -15189000000.0, \"financing_cf_fmt\": \"-\u00a5152\u5104\", \"free_cf\": 15006000000.0, \"free_cf_fmt\": \"\u00a5150\u5104\", \"net_margin\": 8.04, \"roe\": 3.81, \"roa\": 3.19}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-8125","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>HISAMITSU PHARMACEUTICAL CO INC - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4530\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4530\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4530\/\",\"name\":\"HISAMITSU PHARMACEUTICAL CO INC - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2025-12-22T06:34:12+00:00\",\"dateModified\":\"2026-08-23T04:45:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4530\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4530\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4530\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HISAMITSU PHARMACEUTICAL CO INC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HISAMITSU PHARMACEUTICAL CO INC - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4530\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4530\/","url":"https:\/\/japanir.jp\/en\/company\/company-4530\/","name":"HISAMITSU PHARMACEUTICAL CO INC - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2025-12-22T06:34:12+00:00","dateModified":"2026-08-23T04:45:04+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4530\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4530\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4530\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"HISAMITSU PHARMACEUTICAL CO INC"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/8125","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=8125"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=8125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}